The Oncology Institute of Hope and Innovation

Pasadena, CA

Sorting 1 by

Accepting patients

DREAMM-10

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Belantamab Mafodotin, Lenalidomide and Dexamethasone Versus Daratumumab, Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma who are Ineligible for Autologous Stem Cell Transplant
Learn more
  • Antibody Drug Conjugate (ADC)
  • BCMA
  • Phase 3